Bristol’s Goal: 2 New Biologics/Year In Clinic – R&D Chief

Bristol-Myers Squibb’s R&D team plans to boost discovery output by 50 percent with only a modest increase in spending over three years, exec says.

More from Archive

More from Pink Sheet